Authors
Loading...
Randomized trial finds new dopamine D2 receptor ligands in CNS-targeted chemical library, suggesting improved treatment for neuropsychiatric disorders.
Maliyakkal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: